For: | Matsuda M. Clinical value of gadoxetic acid-enhanced magnetic resonance imaging in surgery for hepatocellular carcinoma - with a special emphasis on early hepatocellular carcinoma. World J Hepatol 2015; 7(30): 2933-2939 [PMID: 26730272 DOI: 10.4254/wjh.v7.i30.2933] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v7/i30/2933.htm |
Number | Citing Articles |
1 |
B.G. Tillman, J.D. Gorman, J.M. Hru, M.H. Lee, M.C. King, C.B. Sirlin, R.M. Marks. Diagnostic per-lesion performance of a simulated gadoxetate disodium-enhanced abbreviated MRI protocol for hepatocellular carcinoma screening. Clinical Radiology 2018; 73(5): 485 doi: 10.1016/j.crad.2017.11.013
|
2 |
Yoshiteru Hao, Kazushi Numata, Tomohiro Ishii, Hiroyuki Fukuda, Shin Maeda, Masayuki Nakano, Katsuaki Tanaka. Rate of local tumor progression following radiofrequency ablation of pathologically early hepatocellular carcinoma. World Journal of Gastroenterology 2017; 23(17): 3111-3121 doi: 10.3748/wjg.v23.i17.3111
|
3 |
Masanori Matsuda. 10. Surgical Treatment of Hepatocellular Carcinoma. Japanese Journal of Radiological Technology 2017; 73(4): 319 doi: 10.6009/jjrt.2017_JSRT_73.4.319
|